JACQUES JM
VAN DONGEN
Investigador
Goethe University Frankfurt
Francfort, AlemaniaPublicaciones en colaboración con investigadores/as de Goethe University Frankfurt (13)
2013
-
The MLL recombinome of acute leukemias in 2013
Leukemia, Vol. 27, Núm. 11, pp. 2165-2176
2012
-
The EuroChimerism concept for a standardized approach to chimerism analysis after allogeneic stem cell transplantation
Leukemia, Vol. 26, Núm. 8, pp. 1821-1828
2010
2009
-
New insights to the MLL recombinome of acute leukemias
Leukemia, Vol. 23, Núm. 8, pp. 1490-1499
-
Prognostic significance of minimal residual disease in infants with acute lymphoblastic leukemia treated within the Interfant-99 protocol
Leukemia, Vol. 23, Núm. 6, pp. 1073-1079
2008
-
Translocation detection in lymphoma diagnosis by split-signal FISH: A standardised approach
Journal of Hematopathology, Vol. 1, Núm. 2, pp. 119-126
2007
-
Childhood secondary ALL after ALL treatment
Leukemia, Vol. 21, Núm. 7, pp. 1431-1435
-
Immunobiological diversity in infant acute lymphoblastic leukemia is related to the occurrence and type of MLL gene rearrangement
Leukemia, Vol. 21, Núm. 4, pp. 633-641
2006
-
The MLL recombinome of acute leukemias
Leukemia, Vol. 20, Núm. 5, pp. 777-784
2005
-
Diagnostic tool for the identification of MLL rearrangements including unknown partner genes
Proceedings of the National Academy of Sciences of the United States of America, Vol. 102, Núm. 2, pp. 449-454
2004
-
Rearranged T-cell receptor beta genes represent powerful targets for quantification of minimal residual disease in childhood and adult T-cell acute lymphoblastic leukemia
Leukemia, Vol. 18, Núm. 4, pp. 709-719
-
TCRB gene rearrangements in childhood and adult precursor-B-ALL: Frequency, applicability as MRD-PCR target, and stability between diagnosis and relapse
Leukemia, Vol. 18, Núm. 12, pp. 1971-1980
2003
-
Minimal residual disease prior to stem cell transplant for childhood acute lymphoblastic leukaemia
British Journal of Haematology, Vol. 122, Núm. 1, pp. 24-29